PVLA
Palvella Therapeutics
PVLA
PVLA
88 hedge funds and large institutions have $68.8M invested in Palvella Therapeutics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 33
36% less capital invested
Capital invested by funds: $107M → $68.8M (-$38.4M)
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
88
Holding in Top 10
1
Calls
$67K
Puts
$50K
Top Buyers
| 1 | +$4.93M | |
| 2 | +$1.03M | |
| 3 | +$529K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$513K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$353K |
Top Sellers
| 1 | -$5.2M | |
| 2 | -$3.93M | |
| 3 | -$1.42M | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$930K |
| 5 |
CA
Corriente Advisors
Fort Worth,
Texas
|
-$837K |